RSGGX
Price
$31.75
Change
+$0.36 (+1.15%)
Updated
Jul 6 closing price
Net Assets
1.98B
RWBEX
Price
$81.48
Change
+$0.80 (+0.99%)
Updated
Jul 6 closing price
Net Assets
159.53B
Interact to see
Advertisement

RSGGX vs RWBEX

RSGGX vs RWBEX Comparison Chart in %
View a ticker or compare two or three
VS
RSGGX vs. RWBEX commentary
Jul 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSGGX is a StrongBuy and RWBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWBEX has more cash in the bank: 160B vs. RSGGX (1.98B). RWBEX pays higher dividends than RSGGX: RWBEX (0.95) vs RSGGX (0.65). RSGGX was incepted earlier than RWBEX: RSGGX (15 years) vs RWBEX (12 years). RWBEX (1.21) is less costly to investors than RSGGX (1.12). RWBEX is a more actively managed with annual turnover of: 44.00 vs. RSGGX (34.00). RWBEX has a lower initial minimum investment than RSGGX: RWBEX (250) vs RSGGX (2500). RSGGX annual gain was more profitable for investors over the last year : 21.06 vs. RWBEX (15.57). RSGGX return over 5 years is better than : 67.12 vs. RWBEX (31.82).
RSGGXRWBEXRSGGX / RWBEX
Total Expense Ratio0.851.2170%
Annual Report Gross Expense Ratio1.121.2193%
Fund Existence15 years12 years-
Gain YTD10.91915.06472%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.98B160B1%
Annual Yield % from dividends0.650.9569%
Returns for 1 year21.0615.57135%
Returns for 3 years70.2050.30140%
Returns for 5 years67.1231.82211%
Returns for 10 years186.8397.25192%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRGIX10.99N/A
N/A
VY® CBRE Global Real Estate I
VGHAX89.01N/A
N/A
Vanguard Health Care Adm
MSEQX68.22N/A
N/A
Morgan Stanley Inst Growth I
FRBRX218.09N/A
N/A
Franklin Biotechnology Discovery R6
MUOIX35.49N/A
N/A
Morgan Stanley Instl US Core I